1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pharmacovigilance Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Chemotherapy 1.2.3 Contract Outsourcing 1.3 Market by Application 1.3.1 Global Pharmacovigilance Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Pharma and Biotech Companies 1.3.3 Contract Research Organizations (CROs) 1.3.4 Business Process Outsourcing (BPO) Firms 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pharmacovigilance Market Perspective (2016-2027) 2.2 Pharmacovigilance Growth Trends by Regions 2.2.1 Pharmacovigilance Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Pharmacovigilance Historic Market Share by Regions (2016-2021) 2.2.3 Pharmacovigilance Forecasted Market Size by Regions (2022-2027) 2.3 Pharmacovigilance Industry Dynamic 2.3.1 Pharmacovigilance Market Trends 2.3.2 Pharmacovigilance Market Drivers 2.3.3 Pharmacovigilance Market Challenges 2.3.4 Pharmacovigilance Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pharmacovigilance Players by Revenue 3.1.1 Global Top Pharmacovigilance Players by Revenue (2016-2021) 3.1.2 Global Pharmacovigilance Revenue Market Share by Players (2016-2021) 3.2 Global Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Pharmacovigilance Revenue 3.4 Global Pharmacovigilance Market Concentration Ratio 3.4.1 Global Pharmacovigilance Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Revenue in 2020 3.5 Pharmacovigilance Key Players Head office and Area Served 3.6 Key Players Pharmacovigilance Product Solution and Service 3.7 Date of Enter into Pharmacovigilance Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pharmacovigilance Breakdown Data by Type 4.1 Global Pharmacovigilance Historic Market Size by Type (2016-2021) 4.2 Global Pharmacovigilance Forecasted Market Size by Type (2022-2027) 5 Pharmacovigilance Breakdown Data by Application 5.1 Global Pharmacovigilance Historic Market Size by Application (2016-2021) 5.2 Global Pharmacovigilance Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Pharmacovigilance Market Size (2016-2027) 6.2 North America Pharmacovigilance Market Size by Type 6.2.1 North America Pharmacovigilance Market Size by Type (2016-2021) 6.2.2 North America Pharmacovigilance Market Size by Type (2022-2027) 6.2.3 North America Pharmacovigilance Market Size by Type (2016-2027) 6.3 North America Pharmacovigilance Market Size by Application 6.3.1 North America Pharmacovigilance Market Size by Application (2016-2021) 6.3.2 North America Pharmacovigilance Market Size by Application (2022-2027) 6.3.3 North America Pharmacovigilance Market Size by Application (2016-2027) 6.4 North America Pharmacovigilance Market Size by Country 6.4.1 North America Pharmacovigilance Market Size by Country (2016-2021) 6.4.2 North America Pharmacovigilance Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Pharmacovigilance Market Size (2016-2027) 7.2 Europe Pharmacovigilance Market Size by Type 7.2.1 Europe Pharmacovigilance Market Size by Type (2016-2021) 7.2.2 Europe Pharmacovigilance Market Size by Type (2022-2027) 7.2.3 Europe Pharmacovigilance Market Size by Type (2016-2027) 7.3 Europe Pharmacovigilance Market Size by Application 7.3.1 Europe Pharmacovigilance Market Size by Application (2016-2021) 7.3.2 Europe Pharmacovigilance Market Size by Application (2022-2027) 7.3.3 Europe Pharmacovigilance Market Size by Application (2016-2027) 7.4 Europe Pharmacovigilance Market Size by Country 7.4.1 Europe Pharmacovigilance Market Size by Country (2016-2021) 7.4.2 Europe Pharmacovigilance Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Pharmacovigilance Market Size (2016-2027) 8.2 Asia-Pacific Pharmacovigilance Market Size by Type 8.2.1 Asia-Pacific Pharmacovigilance Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Pharmacovigilance Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Pharmacovigilance Market Size by Type (2016-2027) 8.3 Asia-Pacific Pharmacovigilance Market Size by Application 8.3.1 Asia-Pacific Pharmacovigilance Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Pharmacovigilance Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Pharmacovigilance Market Size by Application (2016-2027) 8.4 Asia-Pacific Pharmacovigilance Market Size by Region 8.4.1 Asia-Pacific Pharmacovigilance Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Pharmacovigilance Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pharmacovigilance Market Size (2016-2027) 9.2 Latin America Pharmacovigilance Market Size by Type 9.2.1 Latin America Pharmacovigilance Market Size by Type (2016-2021) 9.2.2 Latin America Pharmacovigilance Market Size by Type (2022-2027) 9.2.3 Latin America Pharmacovigilance Market Size by Type (2016-2027) 9.3 Latin America Pharmacovigilance Market Size by Application 9.3.1 Latin America Pharmacovigilance Market Size by Application (2016-2021) 9.3.2 Latin America Pharmacovigilance Market Size by Application (2022-2027) 9.3.3 Latin America Pharmacovigilance Market Size by Application (2016-2027) 9.4 Latin America Pharmacovigilance Market Size by Country 9.4.1 Latin America Pharmacovigilance Market Size by Country (2016-2021) 9.4.2 Latin America Pharmacovigilance Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pharmacovigilance Market Size (2016-2027) 10.2 Middle East & Africa Pharmacovigilance Market Size by Type 10.2.1 Middle East & Africa Pharmacovigilance Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Pharmacovigilance Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Pharmacovigilance Market Size by Type (2016-2027) 10.3 Middle East & Africa Pharmacovigilance Market Size by Application 10.3.1 Middle East & Africa Pharmacovigilance Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Pharmacovigilance Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Pharmacovigilance Market Size by Application (2016-2027) 10.4 Middle East & Africa Pharmacovigilance Market Size by Country 10.4.1 Middle East & Africa Pharmacovigilance Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Pharmacovigilance Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eli Lilly and Company 11.1.1 Eli Lilly and Company Company Details 11.1.2 Eli Lilly and Company Business Overview 11.1.3 Eli Lilly and Company Pharmacovigilance Introduction 11.1.4 Eli Lilly and Company Revenue in Pharmacovigilance Business (2016-2021) 11.1.5 Eli Lilly and Company Recent Development 11.2 ICON 11.2.1 ICON Company Details 11.2.2 ICON Business Overview 11.2.3 ICON Pharmacovigilance Introduction 11.2.4 ICON Revenue in Pharmacovigilance Business (2016-2021) 11.2.5 ICON Recent Development 11.3 Elsevier 11.3.1 Elsevier Company Details 11.3.2 Elsevier Business Overview 11.3.3 Elsevier Pharmacovigilance Introduction 11.3.4 Elsevier Revenue in Pharmacovigilance Business (2016-2021) 11.3.5 Elsevier Recent Development 11.4 Chiltern 11.4.1 Chiltern Company Details 11.4.2 Chiltern Business Overview 11.4.3 Chiltern Pharmacovigilance Introduction 11.4.4 Chiltern Revenue in Pharmacovigilance Business (2016-2021) 11.4.5 Chiltern Recent Development 11.5 Atlantic Research Group 11.5.1 Atlantic Research Group Company Details 11.5.2 Atlantic Research Group Business Overview 11.5.3 Atlantic Research Group Pharmacovigilance Introduction 11.5.4 Atlantic Research Group Revenue in Pharmacovigilance Business (2016-2021) 11.5.5 Atlantic Research Group Recent Development 11.6 Mapi Group 11.6.1 Mapi Group Company Details 11.6.2 Mapi Group Business Overview 11.6.3 Mapi Group Pharmacovigilance Introduction 11.6.4 Mapi Group Revenue in Pharmacovigilance Business (2016-2021) 11.6.5 Mapi Group Recent Development 11.7 Accenture 11.7.1 Accenture Company Details 11.7.2 Accenture Business Overview 11.7.3 Accenture Pharmacovigilance Introduction 11.7.4 Accenture Revenue in Pharmacovigilance Business (2016-2021) 11.7.5 Accenture Recent Development 11.8 Clinquest Group 11.8.1 Clinquest Group Company Details 11.8.2 Clinquest Group Business Overview 11.8.3 Clinquest Group Pharmacovigilance Introduction 11.8.4 Clinquest Group Revenue in Pharmacovigilance Business (2016-2021) 11.8.5 Clinquest Group Recent Development 11.9 GSK 11.9.1 GSK Company Details 11.9.2 GSK Business Overview 11.9.3 GSK Pharmacovigilance Introduction 11.9.4 GSK Revenue in Pharmacovigilance Business (2016-2021) 11.9.5 GSK Recent Development 11.10 PRA Health Sciences 11.10.1 PRA Health Sciences Company Details 11.10.2 PRA Health Sciences Business Overview 11.10.3 PRA Health Sciences Pharmacovigilance Introduction 11.10.4 PRA Health Sciences Revenue in Pharmacovigilance Business (2016-2021) 11.10.5 PRA Health Sciences Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pharmacovigilance Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Chemotherapy Table 3. Key Players of Contract Outsourcing Table 4. Global Pharmacovigilance Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Pharmacovigilance Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Pharmacovigilance Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Pharmacovigilance Market Share by Regions (2016-2021) Table 8. Global Pharmacovigilance Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Pharmacovigilance Market Share by Regions (2022-2027) Table 10. Pharmacovigilance Market Trends Table 11. Pharmacovigilance Market Drivers Table 12. Pharmacovigilance Market Challenges Table 13. Pharmacovigilance Market Restraints Table 14. Global Pharmacovigilance Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Pharmacovigilance Market Share by Players (2016-2021) Table 16. Global Top Pharmacovigilance Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance as of 2020) Table 17. Ranking of Global Top Pharmacovigilance Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Pharmacovigilance Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Pharmacovigilance Product Solution and Service Table 21. Date of Enter into Pharmacovigilance Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Pharmacovigilance Market Size by Type (2016-2021) (US$ Million) Table 24. Global Pharmacovigilance Revenue Market Share by Type (2016-2021) Table 25. Global Pharmacovigilance Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Pharmacovigilance Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Pharmacovigilance Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Pharmacovigilance Revenue Market Share by Application (2016-2021) Table 29. Global Pharmacovigilance Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Pharmacovigilance Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Pharmacovigilance Market Size by Type (2016-2021) (US$ Million) Table 32. North America Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Pharmacovigilance Market Size by Application (2016-2021) (US$ Million) Table 34. North America Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Pharmacovigilance Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Pharmacovigilance Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Pharmacovigilance Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Pharmacovigilance Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Pharmacovigilance Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Pharmacovigilance Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Pharmacovigilance Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Pharmacovigilance Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Pharmacovigilance Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Pharmacovigilance Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million) Table 61. Eli Lilly and Company Company Details Table 62. Eli Lilly and Company Business Overview Table 63. Eli Lilly and Company Pharmacovigilance Product Table 64. Eli Lilly and Company Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million) Table 65. Eli Lilly and Company Recent Development Table 66. ICON Company Details Table 67. ICON Business Overview Table 68. ICON Pharmacovigilance Product Table 69. ICON Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million) Table 70. ICON Recent Development Table 71. Elsevier Company Details Table 72. Elsevier Business Overview Table 73. Elsevier Pharmacovigilance Product Table 74. Elsevier Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million) Table 75. Elsevier Recent Development Table 76. Chiltern Company Details Table 77. Chiltern Business Overview Table 78. Chiltern Pharmacovigilance Product Table 79. Chiltern Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million) Table 80. Chiltern Recent Development Table 81. Atlantic Research Group Company Details Table 82. Atlantic Research Group Business Overview Table 83. Atlantic Research Group Pharmacovigilance Product Table 84. Atlantic Research Group Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million) Table 85. Atlantic Research Group Recent Development Table 86. Mapi Group Company Details Table 87. Mapi Group Business Overview Table 88. Mapi Group Pharmacovigilance Product Table 89. Mapi Group Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million) Table 90. Mapi Group Recent Development Table 91. Accenture Company Details Table 92. Accenture Business Overview Table 93. Accenture Pharmacovigilance Product Table 94. Accenture Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million) Table 95. Accenture Recent Development Table 96. Clinquest Group Company Details Table 97. Clinquest Group Business Overview Table 98. Clinquest Group Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million) Table 99. Clinquest Group Recent Development Table 100. GSK Company Details Table 101. GSK Business Overview Table 102. GSK Pharmacovigilance Product Table 103. GSK Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million) Table 104. GSK Recent Development Table 105. PRA Health Sciences Company Details Table 106. PRA Health Sciences Business Overview Table 107. PRA Health Sciences Pharmacovigilance Product Table 108. PRA Health Sciences Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million) Table 109. PRA Health Sciences Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Pharmacovigilance Market Share by Type: 2020 VS 2027 Figure 2. Chemotherapy Features Figure 3. Contract Outsourcing Features Figure 4. Global Pharmacovigilance Market Share by Application: 2020 VS 2027 Figure 5. Pharma and Biotech Companies Case Studies Figure 6. Contract Research Organizations (CROs) Case Studies Figure 7. Business Process Outsourcing (BPO) Firms Case Studies Figure 8. Others Case Studies Figure 9. Pharmacovigilance Report Years Considered Figure 10. Global Pharmacovigilance Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Pharmacovigilance Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Pharmacovigilance Market Share by Regions: 2020 VS 2027 Figure 13. Global Pharmacovigilance Market Share by Regions (2022-2027) Figure 14. Global Pharmacovigilance Market Share by Players in 2020 Figure 15. Global Top Pharmacovigilance Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Pharmacovigilance Revenue in 2020 Figure 17. Global Pharmacovigilance Revenue Market Share by Type (2016-2021) Figure 18. Global Pharmacovigilance Revenue Market Share by Type (2022-2027) Figure 19. North America Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Pharmacovigilance Market Share by Type (2016-2027) Figure 21. North America Pharmacovigilance Market Share by Application (2016-2027) Figure 22. North America Pharmacovigilance Market Share by Country (2016-2027) Figure 23. United States Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Pharmacovigilance Market Share by Type (2016-2027) Figure 27. Europe Pharmacovigilance Market Share by Application (2016-2027) Figure 28. Europe Pharmacovigilance Market Share by Country (2016-2027) Figure 29. Germany Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Pharmacovigilance Market Share by Type (2016-2027) Figure 37. Asia-Pacific Pharmacovigilance Market Share by Application (2016-2027) Figure 38. Asia-Pacific Pharmacovigilance Market Share by Region (2016-2027) Figure 39. China Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Pharmacovigilance Market Share by Type (2016-2027) Figure 47. Latin America Pharmacovigilance Market Share by Application (2016-2027) Figure 48. Latin America Pharmacovigilance Market Share by Country (2016-2027) Figure 49. Mexico Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Pharmacovigilance Market Share by Type (2016-2027) Figure 53. Middle East & Africa Pharmacovigilance Market Share by Application (2016-2027) Figure 54. Middle East & Africa Pharmacovigilance Market Share by Country (2016-2027) Figure 55. Turkey Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Eli Lilly and Company Revenue Growth Rate in Pharmacovigilance Business (2016-2021) Figure 59. ICON Revenue Growth Rate in Pharmacovigilance Business (2016-2021) Figure 60. Elsevier Revenue Growth Rate in Pharmacovigilance Business (2016-2021) Figure 61. Chiltern Revenue Growth Rate in Pharmacovigilance Business (2016-2021) Figure 62. Atlantic Research Group Revenue Growth Rate in Pharmacovigilance Business (2016-2021) Figure 63. Mapi Group Revenue Growth Rate in Pharmacovigilance Business (2016-2021) Figure 64. Accenture Revenue Growth Rate in Pharmacovigilance Business (2016-2021) Figure 65. Clinquest Group Revenue Growth Rate in Pharmacovigilance Business (2016-2021) Figure 66. GSK Revenue Growth Rate in Pharmacovigilance Business (2016-2021) Figure 67. PRA Health Sciences Revenue Growth Rate in Pharmacovigilance Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Eli Lilly and Company ICON Elsevier Chiltern Atlantic Research Group Mapi Group Accenture Clinquest Group GSK PRA Health Sciences